BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3887140)

  • 1. Tumor-associated immunity and serum blocking by radioisotopic leukocyte adherence inhibition assay.
    Tsang PH; Holland JF; Bekesi JG
    Mt Sinai J Med; 1985 Mar; 52(3):193-200. PubMed ID: 3887140
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of the state of antitumor immunity and of serum blocking action in stomach cancer by using the leukocyte adherence inhibition reaction].
    Grishchenko AM; Grinevich IuA; Alferov AN; Redkousova SF; Sen'ko LN
    Vrach Delo; 1978 Aug; (8):28-32. PubMed ID: 695500
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
    Halliday WJ; Maluish AE; Stephenson PM; Davis NC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
    Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of surgery on antitumor immunity measured by tube leukocyte adherence inhibition assay in breast cancer.
    Flores M; Thomson DM; MacFarlane JK
    Surg Forum; 1976; 27(62):91-3. PubMed ID: 1020006
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of leukocyte adherence inhibition test to study the cell mediated antitumour immunity in cancer patients.
    Shirodkar SR; Gangal SG
    Indian J Med Res; 1979 Jul; 70():88-96. PubMed ID: 387584
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
    Storch H; Granetzny A
    Z Gesamte Inn Med; 1987 Jan; 42(2):41-4. PubMed ID: 3554795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of leukocyte adherence inhibition.
    Howell JH
    Cancer Res; 1979 Feb; 39(2 Pt 2):556-7. PubMed ID: 367581
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serum blocking factors on leukocyte adherence inhibition in breast cancer patients: specificity and correlation with tumor burden.
    Yonemoto RH; Fujisawa T; Waldman SR
    Cancer; 1978 Apr; 41(4):1289-97. PubMed ID: 638993
    [No Abstract]   [Full Text] [Related]  

  • 19. [Demonstration of cellular immunity by means of the leukocyte adherence inhibition (LAI) test in female breast neoplasms].
    Fritze D; Ellinger K; Mayer D; Kaufmann M; Drings P; Döhnert G
    Verh Dtsch Ges Inn Med; 1978; (84):577-9. PubMed ID: 742076
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical value of the tube leukocyte adherence inhibition assay in diagnosis and prognosis of breast cancer.
    Lopez MJ; O'Connor R; MacFarlane JK; Thomson DM
    Surg Forum; 1977; 28():125-7. PubMed ID: 364712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.